Lisanti Capital Growth, LLC - Q2 2017 holdings

$150 Million is the total value of Lisanti Capital Growth, LLC's 112 reported holdings in Q2 2017. The portfolio turnover from Q1 2017 to Q2 2017 was 100.0% .

 Value Shares↓ Weighting
AERI ExitAERIE PHARMACEUTICALS INC$0-4,740
-100.0%
-0.31%
CLVS ExitCLOVIS ONCOLOGY INC$0-3,395
-100.0%
-0.31%
OCLR ExitOCLARO INC$0-24,560
-100.0%
-0.34%
STMP ExitSTAMPS COM INC$0-2,395
-100.0%
-0.40%
ACXM ExitACXIOM CORP$0-12,330
-100.0%
-0.50%
PI ExitIMPINJ INC$0-12,795
-100.0%
-0.55%
IPHI ExitINPHI CORP$0-8,015
-100.0%
-0.56%
RP ExitREALPAGE INC$0-11,290
-100.0%
-0.56%
DLTH ExitDULUTH HLDGS INC$0-19,020
-100.0%
-0.58%
QTNA ExitQUANTENNA COMMUNICATIONS INC$0-20,135
-100.0%
-0.60%
CAKE ExitCHEESECAKE FACTORY INC$0-8,355
-100.0%
-0.76%
MULE ExitMULESOFT INCcl a$0-21,860
-100.0%
-0.76%
NVRO ExitNEVRO CORP$0-5,965
-100.0%
-0.80%
WMGI ExitWRIGHT MED GROUP N V$0-18,345
-100.0%
-0.82%
ATI ExitALLEGHENY TECHNOLOGIES INC$0-33,580
-100.0%
-0.86%
PTEN ExitPATTERSON UTI ENERGY INC$0-26,000
-100.0%
-0.90%
TCBI ExitTEXAS CAPITAL BANCSHARES INC$0-7,805
-100.0%
-0.93%
ZEN ExitZENDESK INC$0-25,345
-100.0%
-1.02%
WAGE ExitWAGEWORKS INC$0-10,190
-100.0%
-1.06%
WAL ExitWESTERN ALLIANCE BANCORP$0-15,295
-100.0%
-1.08%
X ExitUNITED STATES STL CORP NEW$0-22,730
-100.0%
-1.10%
GKOS ExitGLAUKOS CORP$0-16,065
-100.0%
-1.18%
TREX ExitTREX CO INC$0-12,270
-100.0%
-1.22%
CAVM ExitCAVIUM INC$0-12,500
-100.0%
-1.28%
MXL ExitMAXLINEAR INC$0-32,455
-100.0%
-1.30%
SPNC ExitSPECTRANETICS CORP$0-33,685
-100.0%
-1.40%
MB ExitMINDBODY INC$0-40,580
-100.0%
-1.59%
MASI ExitMASIMO CORP$0-12,355
-100.0%
-1.65%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2017-07-28
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
MONOLITHIC PWR SYS INC33Q3 20222.0%
Q2 HLDGS INC31Q2 20242.1%
KINSALE CAP GROUP INC27Q1 20242.7%
BOOT BARN HLDGS INC27Q2 20243.1%
HUBSPOT INC27Q1 20221.6%
PENUMBRA INC27Q2 20231.8%
PLANET FITNESS INC26Q4 20232.7%
REPLIGEN CORP26Q1 20242.7%
PACIRA PHARMACEUTICALS INC25Q2 20242.6%
NEUROCRINE BIOSCIENCES INC25Q2 20241.5%

View Lisanti Capital Growth, LLC's complete holdings history.

Latest filings
TypeFiled
N-PX2024-08-27
13F-HR2024-08-01
13F-HR2024-05-07
13F-HR2024-02-06
13F-HR2023-11-03
13F-HR2023-08-11
13F-HR2023-05-08
13F-HR2023-02-06
13F-HR2022-11-02
13F-HR2022-08-03

View Lisanti Capital Growth, LLC's complete filings history.

Compare quarters

Export Lisanti Capital Growth, LLC's holdings